GHK-Cu Spray 50mg is a research-grade intranasal copper peptide formulation developed for laboratory investigations involving GHK-Cu (Copper Tripeptide-1), extracellular matrix biology, peptide signaling, and molecular pharmacology. The standardized spray formulation supports investigations into peptide stability, copper-peptide interactions, formulation science, and intranasal delivery systems while maintaining rigorous analytical quality standards for Research Use Only applications.
HPLC certified
Independent analysis
Highest standard
Full traceability
GHK-Cu Spray 50mg is an investigational intranasal peptide formulation containing GHK-Cu (Copper Tripeptide-1), a naturally occurring copper-binding tripeptide composed of glycyl-L-histidyl-L-lysine complexed with copper ions. Scientific investigations commonly examine GHK-Cu for its relationship with extracellular matrix biology, copper ion transport, peptide-mediated cellular signaling, gene expression, and molecular regulatory pathways. The intranasal spray presentation enables researchers to investigate formulation stability, analytical reproducibility, peptide integrity, copper-peptide complex stability, and standardized delivery system performance under controlled laboratory conditions.
Current scientific literature frequently associates GHK-Cu investigations with extracellular matrix proteins, collagen biology, metalloproteinase regulation, copper-dependent biochemical pathways, oxidative stress biomarkers, and intracellular signaling. Researchers also compare GHK-Cu with investigational peptides including KPV, TB-500, BPC-157, Epitalon, and MOTS-c to better understand molecular characteristics, formulation behavior, peptide stability, and laboratory applications. Manufactured according to stringent research-grade standards and supported by comprehensive analytical verification, GHK-Cu Spray 50mg provides dependable investigational material for peptide chemistry, molecular biology, formulation science, and laboratory research.
GHK-Cu Spray 50mg is a research-grade intranasal copper peptide formulation developed to support laboratory investigations involving GHK-Cu (Copper Tripeptide-1), extracellular matrix biology, molecular pharmacology, peptide chemistry, intracellular communication, copper-peptide interactions, formulation science, and cellular biology research. GHK-Cu is a naturally occurring copper-binding tripeptide consisting of the amino acid sequence glycine-histidine-lysine (GHK) complexed with divalent copper ions. Because of its unique molecular structure and extensive scientific literature, GHK-Cu has become one of the most extensively investigated copper peptides in molecular biology and peptide research. The standardized intranasal spray formulation enables researchers to investigate peptide stability, formulation science, analytical reproducibility, copper complex integrity, and delivery characteristics under controlled laboratory conditions.
A primary area of GHK-Cu research focuses on its relationship with extracellular matrix biology. Researchers investigate peptide-mediated signaling involving collagen-associated proteins, extracellular matrix remodeling, matrix metalloproteinases (MMPs), copper-dependent enzymes, and molecular regulatory pathways to better understand extracellular communication within experimental systems. These investigations remain exclusively within Research Use Only laboratory applications.
Scientific investigations also examine GHK-Cu in relation to intracellular signaling pathways involving gene expression, transforming growth factor-beta (TGF-β) signaling, oxidative stress biomarkers, mitochondrial biology, transcriptional regulation, protein homeostasis, and peptide-mediated molecular communication. Researchers continue evaluating these pathways to better characterize intracellular regulatory mechanisms and copper-peptide pharmacology in laboratory models.
The 50mg intranasal spray formulation provides additional scientific value by allowing laboratories to investigate formulation stability, spray consistency, peptide integrity, copper complex stability, physicochemical characteristics, analytical reproducibility, and intranasal delivery system performance. Comparative laboratory investigations frequently evaluate spray formulations alongside lyophilized peptide preparations to better understand formulation behavior, stability profiles, analytical characteristics, and standardized laboratory handling procedures.
GHK-Cu Spray is commonly investigated alongside KPV, BPC-157, TB-500, Epitalon, MOTS-c, Thymalin, and additional regulatory peptides. Comparative laboratory studies evaluate peptide sequence, intracellular signaling pathways, molecular stability, analytical chemistry, formulation science, copper coordination chemistry, and peptide pharmacology to better understand similarities and distinctions among regulatory peptide systems.
The 50mg formulation is particularly valuable for laboratories conducting extracellular matrix investigations, peptide characterization, formulation comparison studies, molecular biology research, analytical validation, copper-peptide interaction studies, biomarker discovery, and cellular signaling experiments requiring standardized intranasal investigational materials.
Beyond cellular biology investigations, GHK-Cu Spray serves as an important analytical reference material within peptide chemistry, molecular biology, analytical chemistry, pharmaceutical analysis, proteomics, biochemistry, formulation science, drug delivery research, metalloprotein research, and systems biology. The expanding scientific literature surrounding GHK-Cu provides researchers with valuable investigational material for analytical method development, formulation comparison studies, laboratory quality assurance, and peptide stability investigations.
Each batch of GHK-Cu Spray 50mg is manufactured according to stringent research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include peptide identity confirmation, analytical purity verification, copper complex integrity testing, formulation consistency evaluation, packaging inspection, microbial quality testing where appropriate, and batch-specific quality control documentation. These procedures support reproducibility, consistency, and confidence across independent laboratory investigations.
To preserve formulation quality, GHK-Cu Spray should be stored according to accepted laboratory recommendations for peptide formulations. Appropriate storage conditions, controlled laboratory handling, and adherence to institutional protocols help maintain peptide integrity, copper complex stability, and analytical performance before experimental use.
Although GHK-Cu continues to receive significant scientific attention, research involving copper peptide biology, extracellular matrix regulation, gene expression, copper-dependent molecular pathways, and intranasal peptide formulation science remains active and continues to evolve. Accordingly, GHK-Cu Spray 50mg should be regarded exclusively as an investigational laboratory material intended to support scientific discovery and analytical research.
GHK-Cu Spray 50mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, cosmetic use, or diagnostic purposes.
Be the first to share your experience with this product and help other researchers!
How nasal peptide delivery actually works — the olfactory and trigeminal pathways, bioavailability by molecular weight, and why systemic absorption isn't nose-to-brain delivery.
A dated tracker of peptide regulation in 2026: the 503A Bulks List, the July FDA committee vote, warning letters, recalls and WADA rules, with sources.
Research use only is a label, not a quality grade or a legal shield. See what RUO means on a peptide vial, what it leaves out, and how to read a listing.
(faqs)
